The use of alemtuzumab in patients with relapsing-remitting multiple sclerosis: the Gulf perspective.
Alroughani R, Van Wijmeersch B, Al Khaboori J, Alsharoqi IA, Ahmed SF, Hassan A, Inshasi J, Krieger DW, Shakra M, Shatila AO, Szolics M, Khallaf M, Ezzat A.
Alroughani R, et al. Among authors: shatila ao.
Ther Adv Neurol Disord. 2020 Sep 16;13:1756286420954119. doi: 10.1177/1756286420954119. eCollection 2020.
Ther Adv Neurol Disord. 2020.
PMID: 32973927
Free PMC article.
Review.